Global Site-Specific Drug Delivery Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1344

The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action or is prematurely metabolized or excreted. In other instances, the drug travels rather freely throughout the body and not only acts on the desired target tissues but also causes undesirable effects on nontarget tissues. This lack of target specificity is attributable, for the most part, to the formidable barriers that the body presents to the successful delivery of a drug from its site of administration to its site of action: a drug normally encounters or must by pass various molecules, enzymes, cells, membranes, and organs before reaching its designated target.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Site-Specific Drug Delivery in US$ by following Product Segments.: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel and other.
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm

In 2018, the global Site-Specific Drug Delivery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Site-Specific Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Site-Specific Drug Delivery development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm

Market segment by Type, the product can be split into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other

Market segment by Application, split into
Fungal Infection Therapy
Cancer & Tumor Therapy
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Site-Specific Drug Delivery status, future forecast, growth opportunity, key market and key players.
To present the Site-Specific Drug Delivery development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Site-Specific Drug Delivery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Site-Specific Drug Delivery Market Size Growth Rate by Type (2014-2025)
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.4.4 Liposomal Paclitaxel
1.4.5 Other
1.5 Market by Application
1.5.1 Global Site-Specific Drug Delivery Market Share by Application (2014-2025)
1.5.2 Fungal Infection Therapy
1.5.3 Cancer & Tumor Therapy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Site-Specific Drug Delivery Market Size
2.2 Site-Specific Drug Delivery Growth Trends by Regions
2.2.1 Site-Specific Drug Delivery Market Size by Regions (2014-2025)
2.2.2 Site-Specific Drug Delivery Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Site-Specific Drug Delivery Market Size by Manufacturers
3.1.1 Global Site-Specific Drug Delivery Revenue by Manufacturers (2014-2019)
3.1.2 Global Site-Specific Drug Delivery Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Site-Specific Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2 Site-Specific Drug Delivery Key Players Head office and Area Served
3.3 Key Players Site-Specific Drug Delivery Product/Solution/Service
3.4 Date of Enter into Site-Specific Drug Delivery Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Site-Specific Drug Delivery Market Size by Type (2014-2019)
4.2 Global Site-Specific Drug Delivery Market Size by Application (2014-2019)

5 United States
5.1 United States Site-Specific Drug Delivery Market Size (2014-2019)
5.2 Site-Specific Drug Delivery Key Players in United States
5.3 United States Site-Specific Drug Delivery Market Size by Type
5.4 United States Site-Specific Drug Delivery Market Size by Application

6 Europe
6.1 Europe Site-Specific Drug Delivery Market Size (2014-2019)
6.2 Site-Specific Drug Delivery Key Players in Europe
6.3 Europe Site-Specific Drug Delivery Market Size by Type
6.4 Europe Site-Specific Drug Delivery Market Size by Application

7 China
7.1 China Site-Specific Drug Delivery Market Size (2014-2019)
7.2 Site-Specific Drug Delivery Key Players in China
7.3 China Site-Specific Drug Delivery Market Size by Type
7.4 China Site-Specific Drug Delivery Market Size by Application

8 Japan
8.1 Japan Site-Specific Drug Delivery Market Size (2014-2019)
8.2 Site-Specific Drug Delivery Key Players in Japan
8.3 Japan Site-Specific Drug Delivery Market Size by Type
8.4 Japan Site-Specific Drug Delivery Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Site-Specific Drug Delivery Market Size (2014-2019)
9.2 Site-Specific Drug Delivery Key Players in Southeast Asia
9.3 Southeast Asia Site-Specific Drug Delivery Market Size by Type
9.4 Southeast Asia Site-Specific Drug Delivery Market Size by Application

10 India
10.1 India Site-Specific Drug Delivery Market Size (2014-2019)
10.2 Site-Specific Drug Delivery Key Players in India
10.3 India Site-Specific Drug Delivery Market Size by Type
10.4 India Site-Specific Drug Delivery Market Size by Application

11 Central & South America
11.1 Central & South America Site-Specific Drug Delivery Market Size (2014-2019)
11.2 Site-Specific Drug Delivery Key Players in Central & South America
11.3 Central & South America Site-Specific Drug Delivery Market Size by Type
11.4 Central & South America Site-Specific Drug Delivery Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Site-Specific Drug Delivery Introduction
12.1.4 Johnson & Johnson Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Site-Specific Drug Delivery Introduction
12.2.4 Gilead Sciences Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.2.5 Gilead Sciences Recent Development
12.3 Pacira
12.3.1 Pacira Company Details
12.3.2 Company Description and Business Overview
12.3.3 Site-Specific Drug Delivery Introduction
12.3.4 Pacira Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.3.5 Pacira Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Site-Specific Drug Delivery Introduction
12.4.4 Sun Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.4.5 Sun Pharmaceutical Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Site-Specific Drug Delivery Introduction
12.5.4 Luye Pharma Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau Group
12.6.1 Sigma-Tau Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Site-Specific Drug Delivery Introduction
12.6.4 Sigma-Tau Group Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.6.5 Sigma-Tau Group Recent Development
12.7 Fudan-Zhangjiang
12.7.1 Fudan-Zhangjiang Company Details
12.7.2 Company Description and Business Overview
12.7.3 Site-Specific Drug Delivery Introduction
12.7.4 Fudan-Zhangjiang Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.7.5 Fudan-Zhangjiang Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Site-Specific Drug Delivery Introduction
12.8.4 Teva Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.8.5 Teva Pharmaceutical Recent Development
12.9 CSPC
12.9.1 CSPC Company Details
12.9.2 Company Description and Business Overview
12.9.3 Site-Specific Drug Delivery Introduction
12.9.4 CSPC Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.9.5 CSPC Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Site-Specific Drug Delivery Introduction
12.10.4 Novartis Revenue in Site-Specific Drug Delivery Business (2014-2019)
12.10.5 Novartis Recent Development
12.11 Kingond Pharm

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details